Composite gel for removing residual stone fragments after lithotripsy

2:

• The composition gel according to claim 1, wherein the at least one of the component A and the component B contains plasminogen;
• a concentration of the plasminogen is in a range of 1/256 to 1 of a concentration range of 0.1 mg/ml-1 mg/ml.

3-10. (canceled)

11:

• The composition gel according to claim 2, wherein the concentration of the plasminogen is in a range of 1/64 to 1 of the concentration range of 0.1 mg/ml-1 mg/ml.

12:

• The composition gel according to claim 2, wherein the concentration of the plasminogen is in a range of 1/45 to 1/20 or 1/32 to ⅛ of the concentration range of 0.1 mg/ml-1 mg/ml.

13:

• The composition gel according to claim 2, wherein the concentration of the plasminogen is in a range of 1/35 to 1/25 or 1/10 to ⅛ of the concentration range of 0.1 mg/ml-1 mg/ml.

14:

• The composition gel according to claim 2, wherein the concentration of the plasminogen is in a range of 1/32 or 1/10 of the concentration range of 0.1 mg/ml-1 mg/ml.

15:

• The composition gel according to claim 1, wherein the at least one of the component A and the component B contains a non-cyto toxic colouring agent.

16:

• The composition gel according to claim 2, wherein the at least one of the component A and the component B contains a non-cyto toxic colouring agent.

17:

• The composition gel according to claim 14, wherein the at least one of the component A and the component B contains a non-cyto toxic colouring agent.

18:

• The composition gel according to claim 15, wherein the colouring agent is methylene blue, chlorophyll or indocyanine green.

19:

• The composition gel according to claim 17, wherein the colouring agent is methylene blue, chlorophyll or indocyanine green.

20:

• The composition gel according to claim 18, wherein the colouring agent is the methylene blue with a concentration in a range of 20.0 μg/ml to 60.0 μg/ml.

21:

• The composition gel according to claim 19, wherein the colouring agent is the methylene blue with a concentration in a range of 20.0 μg/ml to 60.0 μg/ml.

22:

• The composition gel according to claim 17, wherein both the fibrinogen and the fibrin stabilizing factor are derived from human or animal blood or blood products.

23:

• The composition gel according to claim 15, wherein the component A further contains normal saline;
• the fibrinogen and the fibrin stabilizing factor are diluted in the normal saline.

24:

• The composition gel according to claim 17, wherein the component A further contains normal saline;
• the fibrinogen and the fibrin stabilizing factor are diluted in the normal saline.

25:

• The composition gel according to claim 24, wherein both the thrombin and the plasminogen are derived from human or animal blood or blood products.

26:

• The composition gel according to claim 24, wherein the component B further contains normal saline, wherein the thrombin is diluted in the normal saline.

27:

• The composition gel according to claim 25, wherein the component B further contains normal saline, wherein the thrombin is diluted in the normal saline.